Mangrove Partners Anebulo Pharmaceuticals, Inc. Transaction History

Mangrove Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.0 - $7.7 $47,040 - $60,368	-7,840 Reduced 1.93%	399,219 $2.83 Million
Q4 2021 Feb 14, 2022	SELL	$5.84 - $7.3 $55,404 - $69,255	-9,487 Reduced 2.28%	407,059 $2.5 Million
Q3 2021 Nov 15, 2021	SELL	$6.55 - $7.77 $78,298 - $92,882	-11,954 Reduced 2.79%	416,546 $2.73 Million
Q2 2021 Aug 16, 2021	BUY	$6.58 - $8.95 $2.82 Million - $3.84 Million	428,500 New	428,500 $2.92 Million

7.31M

Ticker ANEB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,633,200
Market Cap $61.5M
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.